Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lisa von Moltke Insider Profile
4 Followers
Lisa von Moltke, EVP and Chief Medical Officer at Seres Therapeutics, holds 32.41K shares in Seres Therapeutics (Ticker: MCRB), holds 183.01K shares in Cara Therapeutics (Ticker: CARA).
Lisa von Moltke has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lisa von Moltke holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lisa von Moltke
Lisa von Moltke's Trading History
Seres Therapeutics
Nov 19, 2024
EVP and Chief Medical Officer
Uninformative Buy
1.09K
$24.89K
Cara Therapeutics
Jun 06, 2024
Director
Uninformative Buy
―
$55.82K
List of latest transactions for each holding click on a transaction to see Lisa von Moltke's performance on stock
You May Also Like
Lisa von Moltke insider profile FAQ
What is the percentage of profitable transactions made by Lisa von Moltke?
The percentage of profitable transactions made by Lisa von Moltke is ―.
What is the average return per transaction made by Lisa von Moltke?
The average return per transaction made by Lisa von Moltke is ―.
What stocks does Lisa von Moltke hold?
Lisa von Moltke holds: MCRB, CARA stocks.
What was Lisa von Moltke’s latest transaction?
Lisa von Moltke latest transaction was an Uninformative Buy of $1.09K.
What was Lisa von Moltke's most profitable transaction?
Lisa von Moltke’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lisa von Moltke's role in Seres Therapeutics?
Lisa von Moltke's role in Seres Therapeutics is EVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.